Larvol Delta - aTyr-Pharma-Announces-Dosing-of-First-Patient-in-Phase-2-EFZOCONNECT-Study-of-Efzotimod-in-Patients-with-SScILD

Stalaris (efzofitimod) - aTyr Pharma, Kyorin

https://www.globenewswire.com/news-release/2023/10/31/2770137/0/en/aTyr-Pharma-Announces-Dosing-of-First-Patient-in-Phase-2-EFZO-CONNECT-Study-of-Efzofitimod-in-Patients-with-SSc-ILD.html

Oct 31, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next